Marco Ruella, MD

Citirano

	Sve	Od 2018.
Citati	9342	8245
H-indeks	39	36
i10-indeks	97	85

1900

950

475

1425

2013201420152016201720182019202020212022202328 54 141 301 485 711 999 1352 1683 1899 1575

Javni pristup

Prikaži sve

56 članaka

4 članka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Carl JuneUniversity of PennsylvaniaPotvrđena adresa e-pošte na upenn.edu
Saad Sirop KenderianHematology and BMT, Mayo ClinicPotvrđena adresa e-pošte na mayo.edu
Stephan A. GruppProfessor of Pediatrics, University of Pennsylvania School of MedicinePotvrđena adresa e-pošte na email.chop.edu
Martin CarrollAssociate Professor, University of PennsylvaniaPotvrđena adresa e-pošte na mail.med.upenn.edu
Sarah K Tasian, MDChildren's Hospital of Philadelphia & University of Pennsylvania School of MedicinePotvrđena adresa e-pošte na chop.edu
Roberto PasseraDepartment of Medical Sciences, University of Torino-ItalyPotvrđena adresa e-pošte na unito.it
Marco LadettoAO ss Antonio e Biagio e Cesare ArrigoPotvrđena adresa e-pošte na ospedale.al.it
Irene RiccaCittà della Salute e della Scienza - Presidio OIRM/S. Anna - TorinoPotvrđena adresa e-pošte na irenericca.it
Alessandro RambaldiProfessore di Ematologia, Università degli Studi di MilanoPotvrđena adresa e-pošte na unimi.it
Christopher HunterUniversity of PennsyvaniaPotvrđena adresa e-pošte na vet.upenn.edu
Bruce L LevineBarbara and Edward Netter Professor in Cancer Gene Therapy, Department of Pathology and LaboratoryPotvrđena adresa e-pošte na pennmedicine.upenn.edu
Tiziano BarbuiFondazione per la Ricerca Ospedale Maggiore di BergamoPotvrđena adresa e-pošte na asst-pg23.it
Anthony MatoCLL Program at Memorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
Alessandro GianniIEO, University of MilanPotvrđena adresa e-pošte na unimi.it
Mario BoccadoroEmeritus Professor of Hematology, University of Torino, ItalyPotvrđena adresa e-pošte na unito.it
sohail qayyumHolzer ClinicPotvrđena adresa e-pošte na holzer.org
David A ChristianUniversity of PennsylvaniaPotvrđena adresa e-pošte na vet.upenn.edu
Alessandra CarobbioFondazione per la Ricerca Ospedale di Bergamo (FROM)Potvrđena adresa e-pošte na fondazionefrom.it
Maria Luigia RandiProfessore di Medicina Interna, Padua UniversityPotvrđena adresa e-pošte na unipd.it
Federico LussanaHematology and Bone Marrow Transplant Unit ASST Papa Giovanni XXIII BergamoPotvrđena adresa e-pošte na asst-pg23.it

Prati

Marco Ruella, MD

University of Pennsylvania

Potvrđena adresa e-pošte na upenn.edu - Početna stranica

Immunotherapy Chimeric Antigen Receptor T Cells CART19 Lymphoma and Leukemia Resistance


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ... Cancer discovery 5 (12), 1282-1295, 2015	1097	2015
Human chimeric antigen receptor macrophages for cancer immunotherapy M Klichinsky, M Ruella, O Shestova, XM Lu, A Best, M Zeeman, ... Nature biotechnology 38 (8), 947-953, 2020	680	2020
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies M Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ... The Journal of clinical investigation 126 (10), 3814-3826, 2016	534	2016
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell M Ruella, J Xu, DM Barrett, JA Fraietta, TJ Reich, DE Ambrose, ... Nature medicine 24 (10), 1499-1503, 2018	485	2018
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells S Gill, SK Tasian, M Ruella, O Shestova, Y Li, DL Porter, M Carroll, ... Blood, The Journal of the American Society of Hematology 123 (15), 2343-2354, 2014	472	2014
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia JA Fraietta, KA Beckwith, PR Patel, M Ruella, Z Zheng, DM Barrett, ... Blood, The Journal of the American Society of Hematology 127 (9), 1117-1127, 2016	445	2016
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia SS Kenderian, M Ruella, O Shestova, M Klichinsky, V Aikawa, ... Leukemia 29 (8), 1637-1647, 2015	402	2015
Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia MY Kim, KR Yu, SS Kenderian, M Ruella, S Chen, TH Shin, AA Aljanahi, ... Cell 173 (6), 1439-1453. e19, 2018	345	2018
Emerging cellular therapies for cancer S Guedan, M Ruella, CH June Annual review of immunology 37, 145-171, 2019	289	2019
Catch me if you can: leukemia escape after CD19-directed T cell immunotherapies M Ruella, MV Maus Computational and structural biotechnology journal 14, 357-362, 2016	263	2016
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses K Watanabe, Y Luo, T Da, S Guedan, M Ruella, J Scholler, B Keith, ... JCI insight 3 (7), 2018	198	2018
Adoptive immunotherapy for cancer M Ruella, M Kalos Immunological reviews 257 (1), 14-38, 2014	182	2014
Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction N Singh, YG Lee, O Shestova, P Ravikumar, KE Hayer, SJ Hong, XM Lu, ... Cancer discovery 10 (4), 552-567, 2020	181	2020
The Addition of the BTK inhibitor Ibrutinib to anti-CD19 chimeric antigen receptor T cells (CART19) improves responses against mantle cell lymphoma M Ruella, SS Kenderian, O Shestova, JA Fraietta, S Qayyum, Q Zhang, ... Clinical Cancer Research 22 (11), 2684-2696, 2016	177	2016
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia SK Tasian, SS Kenderian, F Shen, M Ruella, O Shestova, M Kozlowski, ... Blood, The Journal of the American Society of Hematology 129 (17), 2395-2407, 2017	159	2017
Overcoming the immunosuppressive tumor microenvironment of Hodgkin lymphoma using chimeric antigen receptor T cells M Ruella, M Klichinsky, SS Kenderian, O Shestova, A Ziober, DO Kraft, ... Cancer discovery 7 (10), 1154-1167, 2017	154	2017
Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy EA Chong, M Ruella, SJ Schuster New England Journal of Medicine 384 (7), 673-674, 2021	150	2021
Next-generation chimeric antigen receptor T-cell therapy: going off the shelf M Ruella, SS Kenderian BioDrugs 31 (6), 473-481, 2017	131	2017
An NK-like CAR T cell transition in CAR T cell dysfunction CR Good, MA Aznar, S Kuramitsu, P Samareh, S Agarwal, G Donahue, ... Cell 184 (25), 6081-6100. e26, 2021	121	2021
Immunogenicity of CAR T cells in cancer therapy DL Wagner, E Fritsche, MA Pulsipher, N Ahmed, M Hamieh, M Hegde, ... Nature reviews Clinical oncology 18 (6), 379-393, 2021	116	2021

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori